Syverson Strege & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-487
Closed -$36.6K 174
2023
Q1
$36.6K Buy
487
+4
+0.8% +$297 0.02% 145
2022
Q4
$38.1K Buy
483
+3
+0.6% +$225 0.02% 142
2022
Q3
$34K Buy
480
+2
+0.4% +$157 0.02% 137
2022
Q2
$38K Buy
478
+3
+0.6% +$235 0.01% 147
2022
Q1
$36K Buy
475
+3
+0.6% +$238 0.04% 141
2021
Q4
$40K Buy
472
+3
+0.6% +$234 0.03% 147
2021
Q3
$35K Buy
469
+2
+0.4% +$159 0.03% 159
2021
Q2
$38K Buy
467
+3
+0.6% +$245 0.03% 147
2021
Q1
$37K Buy
464
+2
+0.4% +$157 0.04% 135
2020
Q4
$39K Buy
+462
New +$38.2K 0.04% 123

Other funds holding CL

Syverson Strege & Co's CL Position: Q2 2023 in Review

Syverson Strege & Co sold out of Colgate-Palmolive (CL) in Q2 2023, closing a stake of 487 shares — an estimated $36.6K sold.

Syverson Strege & Co first reported a position in CL in Q4 2020 and held it in 10 quarters. The position peaked at $40K in Q4 2021. 1,679 funds tracked by Wall St. Rank hold CL as of Q2 2023.

  • Syverson Strege & Co reported no remaining Colgate-Palmolive position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 487 Colgate-Palmolive shares in Q2 2023, an estimated $36.6K.
  • Syverson Strege & Co first reported a position in Colgate-Palmolive in Q4 2020 and held it in 10 quarters.
  • Syverson Strege & Co's Colgate-Palmolive position peaked at $40K in Q4 2021.
  • 1,679 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.